Although deranged phosphate transport is the fundamental abnormality in X-linked hypophosphatemic (XLH) rickets, it remains unknown if this defect is the consequence of an intrinsic kidney abnormality or aberrant production of a humoral factor. To discriminate between these possibilities, we examined phosphate homeostasis in normal and Hyp mice, subjected to renal crosstransplantation. We initially evaluated the effects of uninephrectomy on the indices of phosphate metabolism that identify the mutant biochemical phenotype. No 
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1. Abbreviations used in this paper: FEP, fractional excretion of phosphate; Pi, phosphate; TRP, tubular reabsorption of phosphate per milliliter of glomerular filtrate, XLH, X-linked hypophosphatemia. serves as a model for the disease, sharing many of the clinical and biochemical abnormalities observed in patients with XLH (2) . Although many investigators have identified deranged phosphate (Pi) transport in the renal proximal tubule of the murine homologue as the primary abnormality underlying this disease (3, 4) , it remains unknown whether this defect is the consequence of an intrinsic kidney abnormality, or results from production of a humoral factor that alters proximal tubule brush border membrane function. Indeed, these possibilities have been inadequately explored, and previous studies have produced conflicting data. Such investigations include those in which in vivo evaluation of phosphate homeostasis, following parabiotic union of normal and Hyp mice, favored an hormonal cause (5) (6) (7) , and those in which comparison of phosphate transport in cell cultures derived from proximal tubules of these animal models indicated the presence of an intrinsic renal abnormality (8) (9) (10) . Each of these experimental approaches, however, is fraught with significant limitations, and neither permits simultaneous investigation ofthe independent influences ofrenal and humoral factors on phosphate metabolism. In contrast, renal crosstransplantation in normal and Hyp mice, and subsequent assessment of phosphate transport in normal kidneys, engrafted in a genetically abnormal hormonal/metabolic domain, and kidneys from mutant animals, transplanted into a normal metabolic milieu, permit examination of both possibilities. Therefore, in the present study, we used the technique of crosstransplantation to comprehensively examine if the disordered phosphate transport in XLH results from a primary or secondary disturbance of kidney function.
Methods

Animals
Normal C57BL/6J mice were mated with C57BL/6J heterozygous female Hyp mice, as previously described (1 1) . Male Hyp and normal mice obtained from the resultant litters were selected for study at 6-8 wk ofage. All animals received an appropriate diet (as described below) and deionized water ad lib. from weaning until the time of study.
Experimental protocols CHARACTERIZATION OF THE HYP MOUSE BIOCHEMICAL PHENOTYPE
Initially we developed the biochemical indices that would permit identification of the Hyp mouse phenotype in subsequent studies in which animals were subjected to renal transplantation. From weaning until sacrifice, normal and Hyp mice received a diet containing 0.6% of both calcium and phosphorus (Teklad Premier Laboratory Diets, Madison, WI). Identical numbers of normal and Hyp mice mice were sham operated, leaving both kidneys undisturbed, and at l-wk intervals thereafter blood obtained via retroorbital sinus puncture for determination of the plasma phosphorus concentration. 4 wk postoperatively, the animals were anesthetized (65 mg/kg phenobarbital i.p.), and the fractional excretion of phosphate (FEP) and tubular reabsorption of phosphate per milliliter of glomerular filtrate (TRP) deter-mined. At the end ofthe clearance procedure the animals were euthanized by exsanguination. In addition, phosphate-depleted (normal) mice were evaluated in order to establish the criteria to differentiate hypophosphatemia of differing origins. These normal mice were fed a phosphorus-deficient diet (0.2% inorganic phosphorus, 0.6% calcium; Teklad Premier Laboratory Diets) for 1 wk before phosphate clearance studies.
Evaluation ofphosphate clearance. Phosphate clearance was measured by previously established methods (12) . After animals were anesthetized with pentobarbital, a silastic catheter (0.012 in. id, 0.025 in. od; Dow Corning Corp., Midland, MI) was placed in the left jugular vein for infusion of ['4C]Inulin (New England Nuclear, Boston, MA).
The right carotid artery was catheterized with tubing (PE-10; Clay Adams, Parsippany, NJ) for electronic monitoring of blood pressure (Comfort Electronics, Durham, NC) and arterial blood collection. In addition, a catheter (PE-50; Clay Adams) was inserted through a suprapubic incision into a nick in the bladder wall for urine collection. Recipient mice were anesthetized with 4% Halothane and maintained with a concentration of 1.5%. Heparin (1,000 U/ml; Elkins-Sinn Inc., Cherry Hill, NJ) was administered to both recipient and donor mice. After a left nephrectomy, the abdominal aorta and vena cava were dissected and separated, and the recipient mouse was set aside.
The donor kidney was obtained by ligating the preplaced ligatures and severing the vessels/urethra distal to the ties. The kidney, urethra, and bladder were then placed in an ice-cold solution of0.1 ml heparin/ 20 ml stock solution (4.5 g sodium chloride, 100 g mannitol, and 1 g Chloromycetin Sodium/liter sterile water).
In the recipients, vascular clamps were placed proximally and distally in preparation for aorotomy and venotomy. The free proximal ends of the donor aorta and vena cava were sutured to the respective recipient aorta and vena cava with 11-0 Dermalon, and the vascular clamps removed. The proximal 1/5 of the recipient bladder and the proximal 2/3 of the donor bladder were excised in preparation for creating a new urinary bladder in the transplanted mouse. The remaining 1/3 ofthe donor bladder with its attatched ureter was sutured to the remaining 4/5 of the recipient bladder, using 10-0 Novafil.
The abdominal wall and skin were closed separately with continuous sutures of 4-0 silk. 4 d after transplantation, the engrafted mouse was anesthetized with Halothane and a nephrectomy performed on the remaining native kidney.
Analytical methodology
Urine volume was determined by weighing. Plasma (14) and urine (15) inorganic phosphorus were determined by a colorimetric technique.
Statistical methods
All results are expressed as the mean ±SE. Significance ofthe difference between groups was evaluated using paired t testing and analysis of variance (with appropriate a posteriori multiple range comparison procedures) (16). 4-10 animals comprised each experimental group.
Results
Characterization ofthe Hyp mouse biochemical phenotype
The serum phosphorus concentration in Hyp and phosphatedepleted mice, although characteristically decreased to a level significantly less than that in normals, did not distinguish these animal models (Fig. 1) . However, Hyp mice exhibited an FEP far in excess of that manifested by phosphate-depleted mice, and a TRP that was twofold less than that in either normals or phosphate-depleted normals ( Fig. 1 (Fig. 2 A) . Similarly, uninephrectomy had no effect on the plasma phosphorus values in either animal model (Fig. 3 A) , and the presence of a single kidney did not significantly alter the measures of renal phosphate handling, FEP and TRP (Fig. 4 A) . These (Fig. 2 B) . Moreover, this procedure did not affect phosphate homeostasis. 4 wk after surgery, normal mice engrafted with a normal kidney maintained a plasma phosphorus level significantly greater than Hyp mice transplanted with a mutant kidney (Fig. 3 B) , a relationship identical to that observed in both sham-operated and uninephrectomized animals. Indeed, throughout the postoperative interval, the engrafted normal mice did not vary their plasma phosphorus (9.6-10.8 mg/dl) from the normal range, while transplanted Hyp mice exhibited a persistently decreased plasma phosphorus, 5.4-6.4 mg/dl, (Fig. 5 A) . Renal (Fig. 4 B) . Thus, the FEP in the transplanted mutants was no different from that of engrafted normals, in spite ofa remarkably diminished filtered phosphate load, and the TRP was twofold reduced (Fig. 4 B) (Fig. 2 B) . Moreover, the normal mice with kidneys from Hyp mice maintained a plasma phosphorus concentration within the normal range and did not develop the characteristic hypophosphatemia of Hyp mice (Fig. 3 B) . In contrast, Hyp mice engrafted with normal kidneys displayed a decreased plasma phosphorus concentration. Furthermore, the inability ofcrosstransplantation to alter the plasma phosphorus levels of graft recipients was persistent and unwavering. Within 1 wk ofsurgery, Hyp mice crosstransplanted with normal kidneys continued to exhibit hypophosphatemia which remained steady state throughout the 4 wk of observation (Fig. 5 B) . Likewise, normal mice engrafted with mutant kidneys maintained normal plasma phosphorus throughout the post-crosstransplantation period.
The normophosphatemia evident in normal mice crosstransplanted with kidneys from Hyp mice was associated with evidence of normal renal phosphate handling. Both FEP and TRP in these animals were no different than those of normal mice bearing normal transplants (Fig. 4 B) . Indeed, these values indicated that the kidney from Hyp mice, resident in the normal host, was fully capable of normal phosphate transport. In contrast, the normal kidney functioning in the mutant milieu exhibited evidence of markedly abnormal renal phosphate transport. Consequently, Hyp mice, crosstransplanted with normal kidneys, displayed an FEP and TRP no different than those of Hyp mice engrafted with kidneys from mutant animals (Fig. 4 B) . Moreover, the TRP of these animals was significantly less than those of the normal mice crosstransplanted with kidneys from Hyp mice.
Discussion
Renal phosphate reabsorption occurs in the proximal convoluted tubule via a sodium-dependent, phosphate cotransporter that mediates apical transport of phosphate from the tubular lumen into the cell (17) . The . l phate metabolism in this genetically determined hypophosphatemic state. This experimental approach provided the opportunity to examine the function of kidneys from Hyp mice in a normal hormonal/metabolic milieu and the function of normal kidneys in the abnormal domain of the mutant. The technique of organ crosstransplantation has been used previously to distinguish whether the phenotypic and/or biochemical characteristics of a variety of genetic diseases result from innate defects in end-organ function and/or systemic hormonal/metabolic influences. Such investigations have identified an intrarenal abnormality as a primary defect in a genetic form of hypertension in the rat (26) , and an intrahepatic defect as causal of deranged uric acid metabolism in Dalmation dogs (27) . In contrast, alterations in the affected host environment have been determined as the primary cause of resistance to arteriosclerosis in pigs with von Willebrand's disease (28), and as primary or coexistent abnormalities in avian muscular dystrophy (29). Central to each of these investigations is elucidation of definitive criteria to identify the abnormal phenotype under study, and documentation that surgical intervention does not alter their expression. In our studies, we observed that measurement of plasma phosphorus and TRP reproducibly discriminates the Hyp mouse from both normal and phosphate-depleted normal mice (Fig. 1) . Moreover, the single kidney model that we employed did not influence expression of these abnormalities in spite of contrary observations in other animal species (30) . Indeed, we found that uninephrectomy and/or renal transplantation between matched murine models did not negatively influence the GFR or alter phosphate clearance in the resultant single kidney. Consequently, the serum phosphorus concentration was unchanged in each treated animal model (Fig. 3) . The surgical intervention that we used, therefore, did not confound interpretation of data from the crosstransplantation studies.
Thus, in contrast to prevailing opinion, our observations after renal crosstransplantation indicate that the expressed abnormality of phosphate reabsorption in XLH does not result from an intrinsic renal defect, but more likely from an hormonal/metabolic abnormality. In this regard, normal mice transplanted with kidneys from Hyp mice maintained a normal plasma phosphorus concentration throughout the postoperative period, and surprisingly, did not develop hypophosphatemia, in spite of functioning grafts from the mutants (Fig. 3) . Furthermore, the normophosphatemia was associated with evidence of normal renal phosphate reabsorption, which included FEP and TRP values well within the normal range. In concert, crosstransplantation of a normal kidney into a Hyp mouse failed to alter the characteristic hypophosphatemia of the graft recipient. Moreover, the Hyp mice engrafted with normal kidneys displayed FEP and TRP values characteristic of the mutant biochemical phenotype (Fig. 4) . All of these changes occurred without variation in the body weight of the host or diminished GFR in the single kidney (Fig. 2) . Therefore, these data illustrate that the Hyp mouse phenotype is neither transferred nor corrected by renal transplantation. Rather, the potential influence of crosstransplanted kidneys from normal or Hyp mice is negated, and their function determined by the hormonal/metabolic milieu of the host animal.
Whether aberrant regulation of renal 25-hydroxyvitamin D-1 a-hydroxylase activity, an additional kidney abnormality in XLH, similarly occurs as a consequence of an abnormal hormonal/metabolic milieu remains unknown. Nevertheless, since studies in the Hyp mouse have documented that the deranged renal enzyme activity is likely localized to the proximal convoluted tubule, the site of defective phosphate transport, the causes of these abnormalities are undoubtedly linked. Indeed, currently available evidence (31) (32) (33) suggests that the enzyme dysfunction is an acquired defect secondary to this abnormality. Thus, the apparent hormonal/metabolic defect in Hyp mice most likely indirectly influences the expressed defect in calcitriol production. Our data agree with previous observations (5, 6) , in which the technique ofparabiotic union was used to demonstrate that normal mice paired with Hyp mice, before and after parathyroidectomy developed hypophosphatemia secondary to a reversible increase in renal phosphate excretion. However, several salient points limit interpretation of these parabiotic studies. In this regard, the serum phosphorus level and the urinary phosphate excretion in the normal parabiont were intermediate between those evident in the complementary Hyp mouse and sham operated normals. Further, normal mice parabiosed to normal mice also exhibited a decrease in serum phosphorus and an increase in urinary phosphate excretion, compared with sham operated normals. Although some of these observations may be the result of an inability to control the crosscirculation rate in a parabiotic union, such confounding alterations in phosphate homeostasis in parabionts may be due to muscle wasting and/or transfer of phosphorus to the phosphate-depleted bones of the mutant. In any case, no data can be generated from study of parabionts regarding the exclusive ability of the kidney from a Hyp mouse to maintain or contribute to the abnormal biochemical profile. Thus, the possibility of a combined defect in the end organ and the host environment cannot be ruled out. Indeed, previous experiments indicate that such a dual abnormality may produce the characteristic phenotype in avian myotonic dystrophy (29). These limitations have precluded definitive conclusions about the hormone dependence of XLH.
In any case, our observations provide no information regarding the identity of the abnormal hormonal/metabolic factor that underlies XLH. Although elevated serum parathyroid hormone levels have been reported in Hyp mice (34) , this alteration of the metabolic milieu unlikely underlies the abnormal Pi homeostasis in the mutants. In this regard, parathyroidectomy of Hyp mice does not alter the serum phosphorus concentration (35) . By contrast, the recent discovery and biochemical characterization ofthe paraneoplastic syndrome, tumor-induced osteomalacia, provides substantial evidence that favors the existence of a unique humoral agent. In this acquired disease, hypophosphatemic rickets/osteomalacia occurs secondary to diminished renal tubular reabsorption of phosphate and abnormally regulated calcitriol production (36) . Moreover, removal of small tumors leads to prompt restoration of the biochemical abnormalities and healing of the bone disease (37, 38) . Consequently, overproduction of a hormone(s), native or ectopic to the tissue of origin, almost certainly underlies this syndrome. The genetic error in XLH, therefore, may result in altered production (or turnover) of such a naturally occurring humoral factor(s).
Moreover, other evidence does exist that supports the possibility of a humoral phosphaturic factor in X-linked hypophosphatemia. Morgan et al. (39) reported that transplantation of a normal kidney into a patient with XLH resulted in continued hypophosphatemia and decreased renal reabsorption of phos-phorus. This evidence is tempered by the tendency of transplanted kidneys in humans to function abnormally and exhibit low renal retention of phosphate (40) . Further, at the time of study in the posttransplantation period, an abnormal hormonal milieu secondary to renal failure likely persisted, and may have influenced phosphate homeostasis.
Regardless, there are additional data that are difficult to reconcile with a humoral origin for XLH. Renal cells from Hyp mice display diminished phosphate uptake (8) (9) (10) and abnormal vitamin D metabolism (8, 41) 
